BLOOD PLASMA DERIVATIVES MARKET ANALYSIS

Regional Analysis

Global Blood Plasma Derivatives Market: Regional Insights

Based on geography, the global blood plasma derivatives market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Among regions, North America is expected to gain highest share in the market during the forecast period owing to the increasing prevalence of various genetic diseases, rising geriatric population, increasing research and development (R&D), and increasing number of plasma collection centres in the region. For instance, in March 2023, BioLife Plasma Services announced the opening of its 200th plasma donation centre in the United States, with new locations in West Springfield, Mass. and Pearland, Texas to address the urgent and growing need for plasma. Individuals with rare and serious conditions will now to receive life-saving plasma therapies.

Europe and Asia Pacific are also expected to witness significant growth in the global blood plasma derivatives market due to the rise in burden of genetic diseases, growing geriatric population, rise in number of plasma collection centres, and increasing research and development in these regions. For instance, in April 2023, Biotest announced the opening of its 10th plasma collection centre in Germany and to contribute to more plasma collection as plasma shortage in Germany and Europe has worsened in recent years due to corona pandemic. Plasma Service Europe GmbH, a subsidiary of Biotest AG, was founded over 20 years ago to strengthen plasma collection in Germany.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa